CY1112194T1 - Μεθοδοι για ρυθμιση φωτοτοξικοτητας - Google Patents

Μεθοδοι για ρυθμιση φωτοτοξικοτητας

Info

Publication number
CY1112194T1
CY1112194T1 CY20111100977T CY111100977T CY1112194T1 CY 1112194 T1 CY1112194 T1 CY 1112194T1 CY 20111100977 T CY20111100977 T CY 20111100977T CY 111100977 T CY111100977 T CY 111100977T CY 1112194 T1 CY1112194 T1 CY 1112194T1
Authority
CY
Cyprus
Prior art keywords
methods
phototoxicity
adjusting
damage
collagen
Prior art date
Application number
CY20111100977T
Other languages
English (en)
Inventor
G T Wondrak
Michael J Roberts
Moonsun Kim
M K Jacobson
E L Jacobson
Original Assignee
Arizona Board Of Regents On Behalf Of The University Of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona Board Of Regents On Behalf Of The University Of Arizona filed Critical Arizona Board Of Regents On Behalf Of The University Of Arizona
Publication of CY1112194T1 publication Critical patent/CY1112194T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Photovoltaic Devices (AREA)
  • Pyridine Compounds (AREA)

Abstract

Η εφεύρεση αυτή αφορά μεθόδους για ρύθμιση φωτοβλάβης μέσω της χρήσης λαμβανομένων από κολλαγόνο μορίων που είτε ενισχύουν είτε αναστέλλουν βλάβη που προκαλείται από υπεριώδες φως.
CY20111100977T 2002-04-19 2011-10-14 Μεθοδοι για ρυθμιση φωτοτοξικοτητας CY1112194T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37403302P 2002-04-19 2002-04-19
EP03728425A EP1496891B1 (en) 2002-04-19 2003-04-17 Methods for modulating phototoxicity

Publications (1)

Publication Number Publication Date
CY1112194T1 true CY1112194T1 (el) 2015-12-09

Family

ID=29251125

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100977T CY1112194T1 (el) 2002-04-19 2011-10-14 Μεθοδοι για ρυθμιση φωτοτοξικοτητας

Country Status (17)

Country Link
US (3) US6992071B2 (el)
EP (1) EP1496891B1 (el)
JP (2) JP4527405B2 (el)
CN (1) CN1298321C (el)
AT (1) ATE516802T1 (el)
AU (1) AU2003234119B2 (el)
CA (2) CA2482320C (el)
CY (1) CY1112194T1 (el)
DK (1) DK1496891T3 (el)
ES (1) ES2367258T3 (el)
HK (1) HK1077761B (el)
IL (2) IL164560A0 (el)
MX (1) MXPA04010228A (el)
NZ (1) NZ535982A (el)
PT (1) PT1496891E (el)
RU (1) RU2301800C2 (el)
WO (1) WO2003088909A2 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE516802T1 (de) * 2002-04-19 2011-08-15 Univ Arizona State Verfahren zur modulierung der phototoxizität
AU2009224813A1 (en) * 2008-03-10 2009-09-17 Basf Se Encapsulated phase change materials in seed coatings
BRPI1009796A2 (pt) * 2009-03-30 2016-08-23 Shiseido Co Ltd composições para aliviar danos induzidos por irradiação ultravioleta

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310461A (en) * 1980-06-23 1982-01-12 E. R. Squibb & Sons, Inc. Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US6309440B1 (en) * 1998-08-25 2001-10-30 Thomas T. Yamashita Method and composition for promoting and controlling growth of plants
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
JPH0797322A (ja) * 1993-09-29 1995-04-11 Shiseido Co Ltd 一重項酸素消去剤
US6013250A (en) * 1995-06-28 2000-01-11 L'oreal S. A. Composition for treating hair against chemical and photo damage
US5681554A (en) * 1995-06-28 1997-10-28 Cosmair, Inc. Composition for treating hair and method for using the same
JP2961074B2 (ja) * 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
JPH09249567A (ja) * 1996-01-12 1997-09-22 Otsuka Pharmaceut Co Ltd 医薬組成物
EP0906078B1 (en) * 1996-05-07 2003-11-12 Eric F. Bernstein Topical use of tempol in the prevention of photoaging
US20010056085A1 (en) * 1996-07-09 2001-12-27 Avner Ramu Methods of using vesicant drug formulations
WO1998011900A2 (en) * 1996-09-18 1998-03-26 Sarill William J Compositions containing cobalamin and amino acids
EP0987266A4 (en) * 1997-03-31 2000-07-26 Wakamoto Pharma Co Ltd BIPHENYL DERIVATIVES AND MEDICAL PREPARATIONS
US6103487A (en) * 1997-08-27 2000-08-15 Merck & Co., Inc. Method of treating cancer
FR2775595B1 (fr) * 1998-03-09 2000-05-05 Seppic Sa Composition synergique comprenant un compose a structure lipoaminoacide et un extrait de menuphar
JPH11255715A (ja) * 1998-03-13 1999-09-21 Kao Corp Ｎ，ｎ−ジ置換アニリン誘導体
US20020006418A1 (en) * 1998-10-13 2002-01-17 John Kung Composition to enhance permeation of topical skin agents
FR2792650B1 (fr) * 1999-04-20 2003-02-28 Oreal Equivalent de peau agee, son procede de preparation et son utilisation
RU2001132323A (ru) * 1999-04-30 2004-02-20 Вальтер ОБЕРТЮР (DE) Антиокислительные аналоги витамина B6
JP2002543129A (ja) * 1999-05-05 2002-12-17 メルク エンド カムパニー インコーポレーテッド 抗微生物剤としての新規なプロリン類
US20020006394A1 (en) * 2000-02-11 2002-01-17 Redmond Robert W. Photochemical tissue bonding
US6464992B2 (en) * 2000-04-14 2002-10-15 University Of Kentucky Research Foundation Topical micronutrient delivery system and uses thereof
WO2002006225A1 (fr) * 2000-07-19 2002-01-24 Kyowa Hakko Kogyo Co., Ltd. Agents de prevention ou de traitement de la dermite atopique
JP2002128651A (ja) * 2000-10-25 2002-05-09 Kose Corp 光老化抑制剤およびそれを含有することを特徴とする皮膚外用剤
EP1357851A4 (en) * 2001-02-05 2005-09-28 Leonard Stephen Buchanan DENTAL FILES WITH MULTIPLE CONICITIES
ATE516802T1 (de) * 2002-04-19 2011-08-15 Univ Arizona State Verfahren zur modulierung der phototoxizität
DE102005000868A1 (de) * 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren

Also Published As

Publication number Publication date
CN1646121A (zh) 2005-07-27
CA2668311C (en) 2011-08-02
US7226937B2 (en) 2007-06-05
HK1077761B (zh) 2007-05-25
JP2010163461A (ja) 2010-07-29
CA2482320A1 (en) 2003-10-30
ES2367258T3 (es) 2011-10-31
RU2301800C2 (ru) 2007-06-27
JP2005534625A (ja) 2005-11-17
NZ535982A (en) 2006-10-27
US20060009416A1 (en) 2006-01-12
IL203968A0 (en) 2011-07-31
DK1496891T3 (da) 2011-10-24
US6992071B2 (en) 2006-01-31
CA2668311A1 (en) 2003-10-30
AU2003234119B2 (en) 2007-02-08
CA2482320C (en) 2010-02-09
PT1496891E (pt) 2011-09-02
EP1496891A4 (en) 2009-10-21
CN1298321C (zh) 2007-02-07
JP4527405B2 (ja) 2010-08-18
RU2004133322A (ru) 2005-08-10
EP1496891A2 (en) 2005-01-19
US20030223941A1 (en) 2003-12-04
MXPA04010228A (es) 2005-06-08
US20050042188A1 (en) 2005-02-24
WO2003088909A3 (en) 2004-02-12
IL203968A (en) 2013-02-28
WO2003088909A2 (en) 2003-10-30
EP1496891B1 (en) 2011-07-20
JP5244150B2 (ja) 2013-07-24
HK1077761A1 (en) 2006-02-24
ATE516802T1 (de) 2011-08-15
IL164560A0 (el) 2005-12-18
AU2003234119A1 (en) 2003-11-03

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
SE0203713D0 (sv) Novel compounds
NO20041493L (no) Kjemiske forbindelser.
BRPI0506679A (pt) métodos de tratar osteoartrite com antagonistas de il-6
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
BRPI0414599A (pt) pirrol-indóis substituìdos
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
CY1107215T1 (el) Υποκατεστημενα παραγωγα πυριδινυλιου και πυριμιδινυλιου ως διαμορφωτες του μεταβολισμου και η θεραπεια των σχετικων με αυτον διαταραχων
TW200619553A (en) Illumination device, motor-vehicle headlight and method for the production of an illumination device
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
CY1113485T1 (el) Ενωσεις γεφυρωμενης-πιπεριδινης τυπου υποκατεστημενης-κινοξαλινης και οι χρησεις εξ' αυτων
EA200801413A1 (ru) Гетероциклические сетр ингибиторы
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
CY1109992T1 (el) Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
BRPI0417992A (pt) método para purificar fsh
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
EA200800785A1 (ru) 4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецептором
EA200701852A1 (ru) Производные аминокислот